No abstract available
Publication types
-
Clinical Trial
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anti-Allergic Agents / administration & dosage
-
Anti-Allergic Agents / pharmacology
-
Anti-Allergic Agents / therapeutic use*
-
Antibodies, Anti-Idiotypic / administration & dosage
-
Antibodies, Anti-Idiotypic / therapeutic use
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Dermatitis, Atopic / drug therapy*
-
Female
-
Humans
-
Immunoglobulin E / blood
-
Immunoglobulin E / drug effects*
-
Immunoglobulin E / genetics
-
Male
-
Middle Aged
-
Omalizumab
-
Treatment Outcome
Substances
-
Anti-Allergic Agents
-
Antibodies, Anti-Idiotypic
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
anti-IgE antibodies
-
Omalizumab
-
Immunoglobulin E